These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 34014806)

  • 1. The Relationship between COVID-19 Severity and Bacillus Calmette-Guérin (BCG)/
    Torun S; Ozkaya S; Şen N; Kanat F; Karaman I; Yosunkaya S; Sengoren Dikis O; Asan A; Aydogan Eroglu S; Semih Atal S; Ayten O; Aksel N; Ermiş H; Özçelik N; Demirelli M; Kara I; Sümer S; Marakoğlu K; Üzer F; Uyar Y; Çiçek T; E Ünsal Z; Vatansev H; Botan Yildirim B; Kuruoğlu T; Atilla A; Ersoy Y; Kandemir B; Durduran Y; Goksin Cihan F; Demirbaş N; Yıldırım F; Tatar D; Akcay MS
    Pathog Glob Health; 2021 Sep; 115(6):405-411. PubMed ID: 34014806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.
    Ręka G; Korzeniowska A; Piecewicz-Szczęsna H
    Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the role of bacillus calmette-guerin vaccination in protection against COVID-19.
    Chauhan A; Singh M; Agarwal A; Jaiswal N; M Lakshmi PV; Singh M
    Int J Mycobacteriol; 2021; 10(4):433-436. PubMed ID: 34916464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial.
    Ten Doesschate T; van der Vaart TW; Debisarun PA; Taks E; Moorlag SJCFM; Paternotte N; Boersma WG; Kuiper VP; Roukens AHE; Rijnders BJA; Voss A; Veerman KM; Kerckhoffs APM; Oever JT; van Crevel R; van Nieuwkoop C; Lalmohamed A; van de Wijgert JHHM; Netea MG; Bonten MJM; van Werkhoven CH
    Clin Microbiol Infect; 2022 Sep; 28(9):1278-1285. PubMed ID: 35489606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors determining COVID-19 pneumonia severity in a country with routine BCG vaccination.
    Aksu K; Naziroğlu T; Özkan P
    Clin Exp Immunol; 2020 Nov; 202(2):220-225. PubMed ID: 32813879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers.
    Rivas MN; Ebinger JE; Wu M; Sun N; Braun J; Sobhani K; Van Eyk JE; Cheng S; Arditi M
    J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33211672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacillus Calmette-Guérin vaccination as defense against SARS-CoV-2 (BADAS): a randomized controlled trial to protect healthcare workers in the USA by enhanced trained immune responses.
    DiNardo AR; Arditi M; Kamat AM; Koster KJ; Carrero S; Nishiguchi T; Lebedev M; Benjamin AB; Avalos P; Lozano M; Moule MG; McCune B; Herron B; Ladki M; Sheikh D; Spears M; Herrejon IA; Dodge C; Kumar S; Hutchison RW; Ofili TU; Opperman LA; Bernard JA; Lerner SP; Udeani G; Neal G; Netea MG; Cirillo JD
    Trials; 2023 Oct; 24(1):636. PubMed ID: 37794431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between Bacillus Calmette Guerin Vaccination Policy and Coronavirus Disease-2019 (COVID-19) Incidence.
    Alyasin S; Kanannejad Z; Esmaeilzadeh H; Nabavizadeh H; Ghatee MA; Amin R
    Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):106-113. PubMed ID: 33639625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
    Charoenlap S; Piromsopa K; Charoenlap C
    Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacillus calmette-guerin as a quick and temporary solution to coronavirus disease-2019.
    Kumari P; Gupta UD; Bhagyawant SS
    Int J Mycobacteriol; 2021; 10(2):105-110. PubMed ID: 34558459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of BCG Revaccination With
    Dos Anjos LRB; da Costa AC; Cardoso ADRO; Guimarães RA; Rodrigues RL; Ribeiro KM; Borges KCM; Carvalho ACO; Dias CIS; Rezende AO; Souza CC; Ferreira RRM; Saraiva G; Barbosa LCS; Vieira TDS; Conte MB; Rabahi MF; Kipnis A; Junqueira-Kipnis AP
    Front Immunol; 2022; 13():841868. PubMed ID: 35392074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using BCG Vaccine to Enhance Nonspecific Protection of Health Care Workers During the COVID-19 Pandemic: A Randomized Controlled Trial.
    Madsen AMR; Schaltz-Buchholzer F; Nielsen S; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Azizi M; Hameed ZN; Johansen IS; Kofoed PE; Krause TG; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Oedegaard ES; Ostenfeld A; Soerensen MK; Wejse C; Netea MG; Aaby P; Benn CS
    J Infect Dis; 2024 Feb; 229(2):384-393. PubMed ID: 37774494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers.
    Harada N; Nakajima Y; Higuchi K; Sekiya Y; Rothel J; Mori T
    Infect Control Hosp Epidemiol; 2006 May; 27(5):442-8. PubMed ID: 16671023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Friend or Foe? Evaluation of BCG Vaccine and Latent Tuberculosis Infection Effect in Patients Diagnosed with COVID-19 Infection].
    Erdem HA; Şanlıdağ G; Çınar E; Yaşar M; Pullukçu H; Taşbakan MS; Çavuşoğlu C; Gökengin D; Işıkgöz Taşbakan M
    Mikrobiyol Bul; 2021 Jul; 55(3):300-310. PubMed ID: 34416798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare Workers (HCWs) and non-HCWs reaction to Bacillus Calmette-Guérin (BCG) in the BATTLE trial.
    Jalalizadeh M; Leme PAF; Buosi K; Dionato FAV; Dal Col LSB; Giacomelli CF; Reis LO
    Vaccine; 2023 Oct; 41(44):6599-6606. PubMed ID: 37743116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European policies on tuberculosis prevention in healthcare workers: Which role for BCG? A systematic review.
    Bo M; Zotti CM
    Hum Vaccin Immunother; 2016 Nov; 12(11):2753-2764. PubMed ID: 27388449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Infection in Healthcare Professionals and General Population During "First Wave" of COVID-19 Pandemic: A Cross-Sectional Study Conducted in Sicily, Italy.
    Costantino C; Cannizzaro E; Verso MG; Tramuto F; Maida CM; Lacca G; Alba D; Cimino L; Conforto A; Cirrincione L; Graziano G; Palmeri S; Pizzo S; Restivo V; Casuccio A; Vitale F; Mazzucco W
    Front Public Health; 2021; 9():644008. PubMed ID: 34055716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.
    Khan MS; Haq I; Qurieshi MA; Majid S; Bhat AA; Qazi TB; Chowdri IN; Sabah I; Kawoosa MF; Lone AA; Nabi S; Sumji IA; Obaid M; Kousar R
    J Hosp Med; 2021 May; 16(5):274-281. PubMed ID: 33929947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inappropriate risk perception for SARS-CoV-2 infection among Italian HCWs in the eve of COVID-19 pandemic.
    Riccò M; Vezzosi L; Balzarini F; Bragazzi NL
    Acta Biomed; 2020 May; 91(3):e2020040. PubMed ID: 32921735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.